Sotera Health


ATLANTA, GA – – (Newsfile Corp. – September 21, 2022) – – Holzer & Holzer, LLC is investigating whether Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC) complied with federal securities laws.  On September 19, 2022, The Chicago Sun-Times reported that a jury found Sotera Health’s Sterigenics business unit liable for a role in causing a woman’s breast cancer due to its release of emissions from the Company’s plant and awarded the plaintiff $363 million. Following this revelation, the Company’s stock price dropped.


If you purchased Sotera Health stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  or Joshua Karr, Esq. at, call our toll-free number at (888) 508-6832, or visit our website at to discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Shares Purchased
Date Puchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date Sold
Number of Shares Sold
Selling Price Per Share
By clicking on the button below, I am requesting Holzer & Holzer, LLC send me documents necessary to retain the firm.